Belocopitt referred to the actions of prepaid companies in the midst of the DNU signed by President Javier Milei
Claudio Belocopitt, owner of Swiss Medical Groupconfirmed that the prepaid will increase “between 40 and 50%” in the monthly fee. The businessman’s announcement was made through a radio interview within the framework of the publication of Decree of Necessity and Urgency (DNU) which President Javier Milei announced yesterday and where a price release was stipulated.
Support for Javier Milei’s DNU
In dialogue with Radio Con Vos, Belocopitt referred to the actions of the prepaid in the middle of DNU which signed the President Javier Milei. “We saw the decree yesterday, we stayed up late analyzing it. It is premature, I cannot make super specific definitions. What is important is that we understand that it is an issue that must be very clear, everyone has been marking it and I particularly do many years: they were going to crash the system against a mountain,” he said.
The businessman made it clear that the health system “I couldn’t do more” and price liberalization “is a measure that should not have been actively operating under the law, if it had been done correctly.” And he added: “The costs were going up the elevator and the updates went down the ladder and that automatically generated a enormous deterioration”.
claudio belocopitt.jpg
Prepaid: for Belocopitt, the increase was already stipulated
At that point in the interview, Belocopitt revealed that he will hold a meeting in the next few hours with the Argentine Health Union as owner of the Swiss Medical Group firm for the purposes of “define practices to get out of a situation extremely alarming in an orderly manner.” In that sense, he confirmed that the prepaid increase will be between 40 and 50% and explained that it will not be as a consequence of Javier Milei’s DNU. “There is no change here, this increase is going to come, It is stated in the update decree itself signed byr Alberto Fernández in December 2022. It is not a different increase than what would have come“he indicated.
Ultimately, he said he was not happy with taking this measure “but when it comes the pharmaceutical industry and they lower our medications with a 100, 120% increase, we have to validate the same because we have patients. “The situation of the system is desperate.”
Source: Ambito
